medigraphic.com
ISSN 0185-3252 (Print)
Revista de la Asociación Médica del Centro Médico ABC

2002, Number 4

<< Back Next >>

An Med Asoc Med Hosp ABC 2002; 47 (4)

Ischemic cardiopathy. Comparative revision between women and men

Espinosa FR, Pavía LAA

Language: Spanish
References: 52
Page: 217-222
PDF size: 41.00 Kb.


ABSTRACT

Each day ischemic cardiopathy in women, gains much more importance due to its morbidity and mortality. Most women remain asymptomatic for cardiovascular disease before menopause occurs, 95% who develop ischemic cardiopathy is after menopause, leveling the frequency with men. Treatments should be similar in both genders. Prognosis is the same as to the men. The severity of the disease is more important than the gender.


REFERENCES

  1. Lehmann JB, Wehner PS, Lehmann CU, Savory LM. Gender bias in the evaluation of chest pain in the emergency department. Am J Cardiol 1996; 77: 641.

  2. Safstrom K, Nielsen NE, Bjorkhoim A et al, and the IRIS Study Group. Unstable coronary artery disease in postmenopausal women: Identifying patients with significant coronary artery disease by basic clinic parameters and exercise test. Eur Heart J 1998; 19: 899.

  3. Kennedy JW, Killip T, Fisher LD et al. The clinical Spectrum of Coronary Artery disease and its Surgical and medical management. 1974-1979. The Coronary Artery Surgery Study. Circulation 1982; 66: III16-23.

  4. Weiner DA, Ryan TJ, Parson L et al. Long-term prognostic value of exercise testing in men and woman from the coronary artery surgery (CASS) registry. Am J Cardiol 1995; 75: 865.

  5. Amanullah AM, Kiat H, Frideman JD et al. Adenosine technetium-99 sestamibi myocardial perfusion SPECT in women: Diagnostic efficacy in detection, of artery disease. J Am Coll Cardiol 1996; 27: 803.

  6. Elhendy A, Geleijnse ML, van Domburg RT et al. Gender differences in the accuracy of dobutamine stress echocardiography for the diagnosis of coronary artery disease. Am J Cardiol 1997; 80: 1414.

  7. Marwuik T, Anderson T, Williams MJ et al. Exercise echocardiography is an accurate and cost-efficient technique for detection of coronary artery disease in women. J Am Coll Cardiol 1995; 26: 335.

  8. Shaw LJ, Miller DD, Romeis JC et al. Gender differences in the noninvasive evaluation and management of patients with suspected coronary artery disease. Ann Intern Med 1994; 120: 559.

  9. O’Rourke RA, Brundage BH, Froeliage VF et al. American College of Cardiology/American Heart Association expert consensus document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. J Am Coll Cardiol 2000; 36: 326-40.

  10. Hecht H, Superko O. Electron Beam Tomography and National Cholesterol Education Program Guidelines in Asymptomatic Women. J Am Coll Cardiol 2001; 37: 1506-1511.

  11. Kim W, Danias P, Stuber M et al. Coronary Magnetic Resonance Angiography for the detection of coronary stenosis. N Engl J Med 2001; 345: 1856-1869.

  12. Sullivan AK, Holdright DR, Wright CA et al. Chest pain in women: Clinical, investigative, and prognostic features. BMJ 1994; 308: 883.

  13. Gurevitz O, Jonas M, Boyco V et al. Clinical profile and long-term prognosis of women < 50 years of age referred for coronary angiography for evaluation of chest pain. Am J Cardiol 2000; 85: 806.

  14. Buchthal SD, den Hollander JA, Merz CN et al. Abnormal myocardial phosphorus-31 nuclear magnetic resonance spectroscopy in women with chest pain but normal coronary angiograms. N Engl J Med 2000; 342: 829.

  15. Jonsdottir LS, Sigfussin N, Sigvaldason H, Thorgeirsson G. Incidence and prevalence of recognized and unrecognized myocardial infarction in women. The Teykjavik Study. Eur Heart J 1998; 19: 1011.

  16. White HD, Barbash GI, Modan M et. al. After correcting for worse baseline characteristics, women treated with thrombolitic therapy for acute myocardial infarction have the same mortality and morbility as men except for a higher incidence of hemorrhagic stroke. The investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Study. Circulation 1003; 88: 2097.

  17. Maynard C, Litwin PE, Martin JS, Weaver WD. Gender differences in the treatment and outcome of acute myocardial infarction: results from the myocardial infarction triage and intervention registry. Arch Intern Med 1992; 152: 972.

  18. Goldberg RJ, O’Donnell C, Yarzebeki J et al. Sex differences and symptom presentation associated with an acute myocardial infarction: A population-based perspective. Am Heart J 1998; 136: 189.

  19. Malacrida R, Genoni M, Maggioni AP et al. For the Third International Study of Infarct Survivors Collaborative Group: a comparation of the early outcome of acute myocardial infarction in women and men. N Eng J Med 1998; 338: 8.

  20. Vaccarino V, Parsons L, Every NR et al. Exbased differences in early mortality after myocardial infarction. National Registry of Myocardial Infarction 2 Participants. N Engl J Med 1999; 341: 217.

  21. Gan SC, Beaver SK, Houck PM et al. Treatment of acute myocardial infarction and 30-day mortality among women and men. N Engl J Med 2000; 343: 8.

  22. Barakat K, Wilkisin P, Suliman A et al. Acute myocardial infarction in women: contribution of treatment variables to adverse outcome. Am Heart J 2000; 140 (5): 740

  23. Marrugate J, Sala J, Massia R et al. For the RESCATE Investigators Mortality differences between men and women following first myocardial infarction. JAMA 1998; 280: 1405.

  24. Kober J, Torp-Pedersen C, Ottesen M et al. On behalf the TRACE study group. Influence of gender on short and long-term mortality after acute myocardial infarction. Am J Cardiol 1996; 77: 1052.

  25. Hochman JS, Tamis JE, Thompson TD et al. For the Global Use to Open Occluded Coronary Arteries in Acute Coronary Syndromes IIb Investigators. Sex, clinical presentation, and outcomes in patients with coronary syndromes. N Engl J Med 1999; 341: 226.

  26. Mendes LA, Davidoff R, Cupples LA et al. Congestive heart failure in patients with coronary artery disease: The gender paradox. Am Heart J 1997; 134: 207.

  27. Kannel WB, Wilson PWF, D’Agostino RB et al. Sudden coronary death in women. Am Heart J 1998; 136: 205.

  28. Braunwald E, Antman EM, Beasley JW et al. ACC/AHA guideline for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients with Unstable Angina). J Am Coll Cardiol 2000; 36: 970.

  29. Scirica BM, Moliterno DJ, Every NR et al. Differences between men and women in the management of unstable angina pectoris. The GUARANTEE Investigators. Am J Cardiol 1999; 84: 1145.

  30. Clarke KW, Gray D, Keating NA et al. Do women with acute myocardial infarction receive the same treatment as men? BMJ 1994; 309: 563.

  31. ISIS-1 Collaborative Group. Randomized trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction. Lancet 1986; 2: 57.

  32. Harpaz D, Benderly M, Goldbourt U et al. For the Israeli BIP Study Group. Effect of aspirin on mortality in women with symptomatic or silent myocardial ischemia. Am J Cardiol 1996; 78: 1215.

  33. Pfeffer MA, Braunwald E, Moye LA et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. N Engl J Med 1992; 327: 669.

  34. Pedersen TR, Kjekshus J, Merg K et al. Cholesterol lowering and the use of healthcare resources: Results of the Scandinavian Simvastatin Study. Circulation 1996; 93: 1796.

  35. Kelsey SF, James M, Holubkov AL et al. Results of percutaneous transluminal coronary angioplasty in women: 1985-1986 NHLBI coronary angioplasty registry. Circulation 1993; 87: 720.

  36. O’Keefe JH, Kim SC, Hall RR et al. Estrogen replacement therapy after coronary angioplasty in women. J Am Coll Cardiol 1997; 29: 1.

  37. Azar RR, Waters DD, McKay RG et al. Short and medium-term outcome differences in women and men after primary percutaneous transluminal mechanical revascularization for acute myocardial infarction. Am J Cardiol 2000; 85: 675.

  38. Mehilli J, Kastrati A, Dirscinger J et al. Differences in prognosis factors and outcomes between women and men undergoing coronary artery stenting. JAMA 2000; 284: 1799.

  39. Barakat MA, Wilkinson P, Suliman A et al. Acute myocardial infarction in women: Contribution of treatment variables to adverse outcome. A Heart J 2000; 140 (5): 740.

  40. Woodfield SL, Lundergan CF, Reiner JS et al. Gender and myocardial infarction; is there a different response to thrombolysis? Am J Cardiol 1997; 29: 35.

  41. Stone GW, Grines CL, Browne KF et al. A comparison of in-hospital outcome in men versus women treated by either thrombolytic therapy or primary coronary angioplasty for acute myocardial infarction. Am J Cardiol 1995; 75: 987.

  42. O’Connor GT, Morton JR, Diehl MJ et al. Differences between men and women in hospital mortality associated with coronary artery bypass graft surgery. Circulation 1993; 88: 2104.

  43. Edwards FH, Carey JS, Grover FL et al. Impact of gender bypass operative mortality. Ann Thorac Sug 1998; 66: 125.

  44. Braundrup-Wognsen G, Berggren H, Hartford M et al. Female sex is associated with increased mortality and morbidity early, but not late, after coronary bypass grafting. Eur Heart J 1996; 17: 1426.

  45. O’Connor NJ, Morton JR, Birkmeyer JD et al. Effect of coronary artery diameter in patients undergoing coronary bypass surgery. Circulation 1996; 93: 652.

  46. Tan ES, van der Meer J, Jan de Kam P et al. Worse clinical outcome but similar graft patency in women versus men one year after coronary artery bypass graft surgery owing to an excess of exposed risk factors in women. J Am Coll Cardiol 1999; 34: 1760.

  47. Hu F, Stampfer M, Manson J et al. Trends in the incidence of coronary heart disease and changes in diet and lifestyle in women. N Engl J Med 2000; 343: 530.

  48. Mendelsohn ME, Karas RH. The prospective effects of estrogen on the cardiovascular system. N Engl J Med 1999; 340: 801.

  49. Bittner V. Estrogens, Lipids and Cardiovascular Disease. No Easy Answer. J Am Coll Cardiol 2001; 37: 431.

  50. Hordis H, Mack W, Lobo R et al. Estrogen in the Prevention of Atherosclerosis. Ann Intern Med 2001; 135: 939.

  51. Hulley S, Gardy D, Bush T et al. For the Heart an Estrogen/progestin Replacement Study (HERS) Research Grup. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 1998; 280: 605.

  52. Herrington DM, Reboussin DM, Broshniham KB et al. Effects of estrogen replacement on the progression of coronary artery atherosclerosis. N Engl J Med 2000; 343: 522.




2020     |     www.medigraphic.com